Sole Source Phadia 250 System Analyzer

SOL #: HT941026N0037Special NoticeSole Source

Overview

Buyer

DEPT OF DEFENSE
Defense Health Agency (Dha)
DEFENSE HEALTH AGENCY HCD WEST
CAMP PENDLETON, CA, 92055, United States

Place of Performance

Tripler Army Medical Center, HI

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

Analysis Instruments, Medical Laboratory Use (6632)

Set Aside

No set aside specified

Timeline

1
Posted
Apr 10, 2026
2
Action Date
Apr 25, 2026, 5:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Health Agency Contracting Activity (DHACA), Healthcare Operation-West (HCO-W), intends to award a firm fixed-price supply purchase for the Phadia 250 System Analyzer, supplies, and reagents to Phadia US Inc. (Thermo Fisher Scientific). This sole source award is for the Laboratory Department at Tripler Army Medical Center, HI. This is a Notice of Intent to Award a Sole Source contract and not a request for competitive quotes. Interested parties challenging this intent must submit a capability statement by April 25, 2026, 1000 Pacific Daylight Time.

Scope of Work

The requirement is for the procurement of the Phadia 250 System Analyzer, along with necessary supplies and reagents, and maintenance services. These items are crucial for performing whole-allergen and allergen component testing, supporting the full spectrum of current and emerging clinical requirements for the military health system.

Contract & Timeline

  • Type: Firm Fixed Price Supply Purchase (Sole Source)
  • NAICS Code: 334516, Analytical Laboratory Instrument Manufacturing (Size Standard: 1,000 employees)
  • PSC: 6632, Analysis Instruments, Medical Laboratory Use
  • Delivery Schedule:
    • Base Period: 30 September 2027
    • Option Period 1: 30 September 2028
    • Option Period 2: 30 September 2029
    • Option Period 3: 30 September 2030
    • Option Period 4: 30 September 2031
    • 52.217-7: 31 March 2032
  • Published Date: April 10, 2026

Justification for Sole Source

The Government's justification for a sole source award to Thermo Fisher Scientific is based on the unique and proprietary nature of the Phadia 250 System and its ImmunoCAP assays. These assays are globally recognized for their analytical performance, reproducibility, and long-term consistency. Alternative systems cannot produce clinically equivalent or interchangeable results, which is essential for maintaining consistent longitudinal patient data and validated diagnostic outcomes across time and locations. The breadth and depth of this capability are not replicated by any other vendor.

Submission & Evaluation

This is not a request for competitive proposals. Sources interested in challenging the sole source intent must submit a capability statement demonstrating their ability to provide the required items. The statement must include management, technical, and cost information, not exceeding six (8.5 x 11 inch) pages with a 10-point font. Information received will be considered solely for determining whether to conduct a competitive procurement or proceed with the sole source purchase order.

Key Deadlines

  • Capability Statement Due: April 25, 2026, 1000 Pacific Daylight Time

Contact Information

People

Points of Contact

Files

Files

Download

Versions

Version 1Viewing
Special Notice
Posted: Apr 10, 2026
Sole Source Phadia 250 System Analyzer | GovScope